186 related articles for article (PubMed ID: 25111164)
1. Coxsackievirus can persist in murine pancreas by deletion of 5' terminal genomic sequences.
Tracy S; Smithee S; Alhazmi A; Chapman N
J Med Virol; 2015 Feb; 87(2):240-7. PubMed ID: 25111164
[TBL] [Abstract][Full Text] [Related]
2. Mutational Disruption of cis-Acting Replication Element 2C in Coxsackievirus B3 Leads to 5'-Terminal Genomic Deletions.
Smithee S; Tracy S; Chapman NM
J Virol; 2015 Dec; 89(23):11761-72. PubMed ID: 26355088
[TBL] [Abstract][Full Text] [Related]
3. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
[TBL] [Abstract][Full Text] [Related]
5. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes.
Tracy S; Drescher KM
Ann N Y Acad Sci; 2007 Apr; 1103():143-51. PubMed ID: 17376828
[TBL] [Abstract][Full Text] [Related]
6. Functional Consequences of RNA 5'-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation.
Lévêque N; Garcia M; Bouin A; Nguyen JHC; Tran GP; Andreoletti L; Semler BL
J Virol; 2017 Aug; 91(16):. PubMed ID: 28539455
[TBL] [Abstract][Full Text] [Related]
7. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.
Tracy S; Drescher KM; Chapman NM; Kim KS; Carson SD; Pirruccello S; Lane PH; Romero JR; Leser JS
J Virol; 2002 Dec; 76(23):12097-111. PubMed ID: 12414951
[TBL] [Abstract][Full Text] [Related]
8. Enterovirus Persistence in Cardiac Cells of Patients With Idiopathic Dilated Cardiomyopathy Is Linked to 5' Terminal Genomic RNA-Deleted Viral Populations With Viral-Encoded Proteinase Activities.
Bouin A; Gretteau PA; Wehbe M; Renois F; N'Guyen Y; Lévêque N; Vu MN; Tracy S; Chapman NM; Bruneval P; Fornes P; Semler BL; Andreoletti L
Circulation; 2019 May; 139(20):2326-2338. PubMed ID: 30755025
[TBL] [Abstract][Full Text] [Related]
9. Replication Activities of Major 5' Terminally Deleted Group-B Coxsackievirus RNA Forms Decrease PCSK2 mRNA Expression Impairing Insulin Maturation in Pancreatic Beta Cells.
Callon D; Guedra A; Lebreil AL; Heng L; Bouland N; Fornès P; Berri F; Andreoletti L
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560784
[TBL] [Abstract][Full Text] [Related]
10. Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes.
Alidjinou EK; Engelmann I; Bossu J; Villenet C; Figeac M; Romond MB; Sané F; Hober D
Virulence; 2017 Oct; 8(7):1229-1244. PubMed ID: 28112573
[TBL] [Abstract][Full Text] [Related]
11. Domain I of the 5' non-translated genomic region in coxsackievirus B3 RNA is not required for productive replication.
Jaramillo L; Smithee S; Tracy S; Chapman NM
Virology; 2016 Sep; 496():127-130. PubMed ID: 27289561
[TBL] [Abstract][Full Text] [Related]
12. The role of B lymphocytes in coxsackievirus B3 infection.
Mena I; Perry CM; Harkins S; Rodriguez F; Gebhard J; Whitton JL
Am J Pathol; 1999 Oct; 155(4):1205-15. PubMed ID: 10514403
[TBL] [Abstract][Full Text] [Related]
13. Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetes.
Alidjinou EK; Sané F; Engelmann I; Geenen V; Hober D
Discov Med; 2014 Nov; 18(100):273-82. PubMed ID: 25425468
[TBL] [Abstract][Full Text] [Related]
14. Enterovirus-Cardiomyocyte Interactions: Impact of Terminally Deleted Genomic RNAs on Viral and Host Functions.
Bouin A; Vu MN; Al-Hakeem A; Tran GP; Nguyen JHC; Semler BL
J Virol; 2023 Jan; 97(1):e0142622. PubMed ID: 36475766
[TBL] [Abstract][Full Text] [Related]
15. Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.
Kanno T; Kim K; Kono K; Drescher KM; Chapman NM; Tracy S
J Virol; 2006 Jun; 80(11):5637-43. PubMed ID: 16699045
[TBL] [Abstract][Full Text] [Related]
16. 5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart.
Chapman NM; Kim KS; Drescher KM; Oka K; Tracy S
Virology; 2008 Jun; 375(2):480-91. PubMed ID: 18378272
[TBL] [Abstract][Full Text] [Related]
17. Coxsackie B virus and its interaction with permissive host cells.
Selinka HC; Huber M; Pasch A; Klingel K; Aepinus C; Kandolf R
Clin Diagn Virol; 1998 Apr; 9(2-3):115-23. PubMed ID: 9645993
[TBL] [Abstract][Full Text] [Related]
18. Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.
Sané F; Moumna I; Hober D
Expert Rev Clin Immunol; 2011 May; 7(3):357-66. PubMed ID: 21595602
[TBL] [Abstract][Full Text] [Related]
19. Replication of coxsackievirus B3 in primary cell cultures generates novel viral genome deletions.
Kim KS; Chapman NM; Tracy S
J Virol; 2008 Feb; 82(4):2033-7. PubMed ID: 18057248
[TBL] [Abstract][Full Text] [Related]
20. Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine.
Alidjinou EK; Sané F; Bertin A; Caloone D; Hober D
Antiviral Res; 2015 Apr; 116():51-4. PubMed ID: 25655448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
